Welcome! Accelerate Your Discovery

Be a part of a committed society that is shaping the future of knowledge Search

Suicide and Suicide Attempts among Patients Attending a District Hospital in Ghana: a Retrospective Study

Article Number: SIS689021AI080125
8th January, 2025
Author(s):
Dennis Bomansang Daliri, Agani Afaya, Timothy Tienbia Laari, Nancy Abagye, Elizabeth Hutchful
Abstract:

Suicide and suicidal attempts have become a public health concern worldwide as it is the second leading cause of death among the youth. Despite its impact on public health, few studies on this menace exist in low- and middle-income countries like Ghana. This study sought to review the data of patients who have been involved in suicide and suicidal attempts in a district hospital in the Upper East Region of Ghana. This is a retrospective review of the records of patients (outpatient and inpatients) who attempted or completed suicide. The study was conducted in the War Memorial Hospital from April to May 2023. Data extraction covered January 2016 to December 2021. The study identified 162 cases of suicide (attempted and completed) with 80 (49.4%) males and 82 (50.6%) females. The mean age of culprits was 32.0±16.1. Even though more females attempted suicide, more males completed it. The commonest method used in suicidal attempts was chemical ingestion (poisoning). Also, the year 2020 recorded the highest number of suicidal attempts and completed suicide (24.7%). People between the ages of 18-25 were found to attempt suicide the most (38.9%). There is a need for urgent education among the youth about suicide. Also, using less poisonous mechanisms for agricultural practices such as adopting organic methods of agriculture may help reduce the accessibility of the pesticides used in suicide attempts.

Share article

Recommended Articles

Argyria
Tin Yan Lee, M.B., C...
Argyria, silver toxicity, skin pigmentation, systemic exposure, dermatopathology, toxicology

Background:An 84-year-old man with benign prostatic hyperplasia was admitted for acute kidney injury... 2 weeks ago

APOL1 Kidney Disease Variants — Information fro...
Simone Sanna-Cherchi...
APOL1, chronic kidney disease, focal segmental glomerulosclerosis, West Africa, genetic variants, Trypanosoma brucei, genotype, ethnolinguistic groups

Background:Chronic kidney disease (CKD) disproportionately affects populations of African ancestry, ... 2 weeks ago

APOL1 Bi- and Monoallelic Variants and Chronic Kid...
R.A. Gbadegesin, I. ...
APOL1, chronic kidney disease, West Africans, genetic variants, focal segmental glomerulosclerosis, case-control study

Background: Apolipoprotein L1 gene (APOL1) variants are risk factors for chronic kidney disease (CKD... 2 weeks ago

A Randomized Trial of Drug Route in Out-of-Hospit...
K. Couper, C. Ji, C....
out-of-hospital cardiac arrest, intraosseous, intravenous, vascular access, epinephrine, randomized trial, survival, neurologic outcome

Background: In patients with out-of-hospital cardiac arrest, the effectiveness of drugs such as epin... 2 weeks ago

A Comparison of Peripherally Inserted Central Cath...
Amanda J. Ullman, De...
peripherally inserted central catheter, PICC, hydrophobic, chlorhexidine, polyurethane, device failure, infectious complications, thrombotic complications, randomized controlled trial

BACKGROUNDNew catheter materials for peripherally inserted central catheters (PICCs) may reduce the ... 2 weeks ago

Case 4-2025: A 41-Year-Old Man with Syncope, Ankle...
Daniel Restrepo, Sad...
Löfgren’s syndrome, Sarcoidosis, Bilateral hilar lymphadenopathy, Erythema nodosum, Inflammatory arthritis, Syncope, Glucocorticoids, Cardiac sarcoidosis, Pulmonary nodules, Autoimmune disease.

A 41-year-old man with a history of coronary artery disease presented with syncope, bilateral ankle ... 2 weeks ago

Case 2-2025: A 21-Year-Old Man with Loss of Consci...
Eric F. Shappell, Br...
Posterior reversible encephalopathy syndrome, Sickle cell disease, Seizure, Vaso-occlusive crisis, Cerebral fat embolism, MRI, Red-cell exchange, Hypertension, Microhemorrhages, Neurologic complications.

A 21-year-old man with sickle cell disease presented with loss of consciousness and a fall, followed... 2 weeks ago

Case 1-2025: A 35-Year-Old Woman with Shortness of...
Jessica S. Tangren, ...
Focal segmental glomerulosclerosis, Nephrotic syndrome, Postpartum complications, Preeclampsia, Proteinuria, Hypoalbuminemia, Kidney biopsy, Hypertension, Edema, Glomerular disease, Immunosuppression, Collapsing glomerulopathy.

A 35-year-old woman presented with postpartum shortness of breath and progressive leg edema. Initial... 2 weeks ago

What’s Next for Nicotine? The Coming Legal and P...
Patricia J. Zettler ...
Nicotine reduction, FDA regulation, tobacco control, addiction, public health policy, legal challenges

BACKGROUNDOn January 16, 2025, the FDA proposed limiting nicotine levels in cigarettes to 0.70 mg pe... 2 weeks ago

The Definition of Heart Failure
Jason Gurney
Heart failure, terminology, patient experience, stigma, chronic disease, renaming

BACKGROUNDHeart failure is a major public health problem, affecting more than 64 million people (1 t... 2 weeks ago

BPROAD — End of the Road for Debate on Systoli...
Shuchi Anand, M.D., ...
Systolic blood pressure, type 2 diabetes, hypertension, cardiovascular risk, intensive therapy, ACCORD BP, SPRINT trial

BACKGROUNDElevated blood pressure mediates much of the organ toxicity affecting persons with type 2 ... 2 weeks ago

Sotatercept in Patients with Pulmonary Arterial Hy...
Marc Humbert et al. ...
Sotatercept, pulmonary arterial hypertension, WHO functional class, REVEAL Lite 2, composite endpoint, hospitalization, mortality

BACKGROUNDSotatercept improves exercise capacity and delays the time to clinical worsening in patien... 2 weeks ago

Severe HDL Cholesterol Reduction with Bempedoic A...
Francesco Sbrana et ...
HDL cholesterol, bempedoic acid, fenofibrate, drug interaction, familial hypercholesterolemia, stomatocytes

A low plasma level of high-density lipoprotein (HDL) cholesterol is a strong, independent predict... 2 weeks ago

Routine Cerebral Embolic Protection during Transc...
Rajesh K. Kharbanda ...
TAVI, cerebral embolic protection, stroke, randomized trial, aortic stenosis, CEP device

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral... 2 weeks ago

Pulsed Field or Cryoballoon Ablation for Paroxys...
Tobias Reichlin et a...
pulsed field ablation, cryoballoon ablation, paroxysmal atrial fibrillation, pulmonary-vein isolation, nonthermal ablation, implantable cardiac monitor, arrhythmia recurrence, catheter ablation, randomized trial, SINGLE SHOT CHAMPION trial

Background: Pulmonary-vein isolation is effective for paroxysmal atrial fibrillation (AF). Pulsed fi... 2 weeks ago

Oral Semaglutide and Cardiovascular Outcomes in H...
D.K. McGuire et al. ...
oral semaglutide, type 2 diabetes, cardiovascular outcomes, GLP-1 receptor agonist, MACE, atherosclerotic cardiovascular disease, chronic kidney disease, myocardial infarction, randomized controlled trial, SOUL trial

Background:The cardiovascular safety of oral semaglutide, a glucagon-like peptide-1 (GLP-1) recep... 2 weeks ago

Modest Blood Pressure Increase with Age in Adults...
Andrea Kelly et al.
Down’s syndrome, blood pressure, hypertension, systolic blood pressure, diastolic blood pressure, pulse pressure, cardiovascular phenotype, aging, BMI, sympathetic activity

Background: In the general population, blood pressure typically rises with age, but this pattern in ... 2 weeks ago

Medium- and Distal-Vessel Occlusion — The Limit ...
J. Mocco, M.D
thrombectomy, stroke, medium-vessel occlusion, distal-vessel occlusion, ESCAPE-MeVO trial, DISTAL trial, ischemic stroke, endovascular therapy, mortality, intracranial hemorrhage

Background: Thrombectomy for stroke has shown significant benefits in large-vessel occlusions, but i... 2 weeks ago

Lorundrostat Efficacy and Safety in Patients with...
L.J. Laffin et al. f...
lorundrostat, hypertension, aldosterone synthase inhibitor, randomized controlled trial, ambulatory blood pressure, hyperkalemia, treatment-resistant hypertension, eGFR, mineralocorticoid, cardiovascular risk

Background: Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone sy... 2 weeks ago

Lepodisiran — A Long-Duration Small Interfering ...
Steven E. Nissen, We...
Lepodisiran, lipoprotein(a), siRNA therapy, cardiovascular disease, RNA interference, ALPACA trial, LDL cholesterol, atherosclerosis, PCSK9 inhibitors, Eli Lilly.

"BACKGROUNDElevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular... 2 weeks ago

Records : 20 of 2150 | Page : of 108 | Limit

Close

Search SIS !

Articles, journal, project, hall of fame

Username or Email
Password

Don't have an account? Register

Do you have an account already? Login

Copyright © Scholar Indexing Society All Rights Reserved.